Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Supreme Court To Decide High-Stakes Abortion Pill Case

The Supreme Court's upcoming decision on mifepristone's approval process could have significant implications for reproductive rights and healthcare access ...

Top News

U.S. Supreme Court takes up Texas case challenging abortion pill access

A majority of Supreme Court justices seemed open to keeping mifepristone, a common abortion-inducing drug, on the market despite a Texas ruling revoking its FDA approval.

The Texas Tribune

SCOTUS abortion pill hearing puts FDA discretion on trial

A ruling against expanded mifepristone access could set a precedent for courts to substitute their own conclusions for agency decisions.

Axios

From analysis to the latest developments in health,
read the most diverse news in one place.

How the abortion pill case at the supreme court could undo the FDA

The mifepristone case is viewed with trepidation by the medical industry and could have enormous consequences for drug regulation

The Guardian - US

US-style executive pay packets in UK would ‘risk higher inequality’

Leading social scientists issue warning after call by business leaders and London Stock Exchange

The Guardian - UK

S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind

S&P 500 stocks DexCom, Blackstone and Royal Caribbean lead five stocks around buy points after Fed chief Jerome Powell helped buoy markets.

Investors Business Daily

How rightwing groups used junk science to get an abortion case before the US supreme court

Anti-abortion researchers ‘exaggerate’ and ‘obfuscate’ in their scientific papers – but by the time they’re published, it’s too late

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Electoral Bonds data | Firms from Telangana, A.P. loosened purse strings for multiple political parties

Companies in Hyderabad purchased electoral bonds for various political parties, revealing significant donations and recipients in Telangana and Andhra Pradesh.

The Hindu

3 Pharma Gems Poised for Breakthroughs

The pharmaceutical industry is rapidly expanding, fueled by continued R&D efforts leading to the discovery of new drugs and therapies, biotechnology innovations, and growing medical needs. Thus, let’s take a look at pharma gems Pacira BioSciences (PCRX), Calliditas Therapeutics (CALT), and Astellas Pharma (ALPMY) poised for breakthroughs. Read more….

StockNews.com

Why some abortion patients go to the ER

A small portion of patients do visit ERs after an abortion, but it's not because mifepristone is unsafe

Salon

3 Pharma Stocks Outperforming the Competition

The growing demand for innovative drugs, the use of advanced technologies, and growing global healthcare needs boost the pharmaceutical industry’s long-term growth prospects. Therefore, fundamentally strong pharma stocks Viatris (VTRS), Wave Life Sciences (WVE), and MEI Pharma (MEIP) might be ideal additions to your portfolio. Read on.

StockNews.com

4 Cutting-Edge Pharma Stocks for Portfolio Diversification

The pharmaceutical industry is expected to grow rapidly due to increasing healthcare demand, technological advancements, and rising demand for innovative drugs. Therefore, for portfolio diversification, investors could consider buying fundamentally strong pharmaceutical stocks such as Bayer (BAYRY), Procaps Group (PROC), ACADIA Pharmaceuticals (ACAD), and Zoetis (ZTS). Read more.

StockNews.com

Many pharma companies that bought electoral bonds faced regulatory actions

Top pharmaceutical companies purchased electoral bonds amidst regulatory scrutiny, including Hetero, MSN, Divi's, Intas, Lupin, Mankind, Micro Labs, and Natco.

The Hindu

3 Pharma Stocks Fueling Investor Enthusiasm

The pharmaceutical industry is expected to expand rapidly due to growing global healthcare needs and advancements in technology. Therefore, fundamentally strong pharma stocks Merck (MRK), AbbVie (ABBV), and GSK plc (GSK) might be ideal additions to your portfolio. Read on.

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Top 3 Pharma Innovators to Watch Closely

The pharmaceutical industry is experiencing considerable growth, driven by rising healthcare needs, continuous advances in drug discovery & discovery, and M&A activity. So, investors could keep a close eye on top pharma stocks Amneal Pharmaceuticals (AMRX), Collegium Pharmaceutical (COLL), and Sanofi (SNY) for potential gains. Keep reading….

Investors Business Daily

Why Abbott's Formula-Related Sell-Off Could Be A Buying Opportunity, Says Analyst

Abbott stock tumbled to a month-low Friday after an Illinois jury ordered Reckitt Benckiser to pay $60 million in an infant formula lawsuit.

StockNews.com

Biotech Investors: Should You Buy, Hold, or Sell Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR)?

Despite facing several challenges, the biotech sector thrives due to growing demand for effective treatments, consistent innovations, and a sustained demand for high-quality drugs and therapies. Let's assess whether one should Buy, Hold, or Sell biotech stocks Moderna (MRNA) and Arrowhead Pharmaceuticals (ARWR). Keep reading.

StockNews.com

3 B-Rated Biotech Stocks to Boost Your Bottom Line

The biotech industry’s growth prospects look promising due to innovative drugs and therapies, government initiatives, and technological advancements. Therefore, investors could consider buying fundamentally strong biotech stocks BioMarin Pharmaceutical (BMRN), Illumina (ILMN), and Harmony Biosciences (HRMY). These stocks are B-rated (Buy) in our proprietary rating system. Read on.

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Biotech Stocks to Jumpstart Your Portfolio Gains

The biotech industry is poised for robust growth due to increasing demand for personalized treatments, rising prevalence of chronic diseases, heightened investments in R&D, and advancements in technology. Therefore, investors could consider buying fundamentally strong biotech stocks Innoviva (INVA), ANI Pharmaceuticals (ANIP), and United Therapeutics (UTHR). Read more.

Investors Business Daily

Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test

Moderna stock surged Monday, nearing its first breakout in over a year, after launching a third study of its cancer vaccine.

Investors Business Daily

MoonLake Jumps After Arthritis Drug Tops AbbVie Blockbuster Humira In A Key Test

Biotech stock MoonLake popped Monday after the company said its experimental psoriatic arthritis treatment beat out AbbVie's Humira.

The Guardian - US

US pharma group opposing abortion pill restrictions also backs Republicans attacking drug

Group advocating to preserve FDA judgment in supreme court case also gave $125,000 to Republicans opposing mifepristone

Kiplinger

Biden Spotlights Drug Prices, Medicare, Social Security in State of the Union

Biden calls for expanding Medicare drug price negotiations to include up to 500 drugs over next decade.

International Business Times

Chemicals Giant Bayer Rules Out Break-up 'For Now' After Huge Loss

CEO Bill Anderson, hired last year to help steer the troubled group in a new direction, ruled out any imminent break-up of the company -- despite mounting pressure from activist investors.

Investors Business Daily

Top 2% Biotech Avidity Tumbles Despite 'Positive' Results In Treating Muscular Dystrophy

Top-notch biotech stock Avidity tumbled Monday despite unveiling "positive" midstage test results for its muscular dystrophy treatment.

1 … 14 15 16 17

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Bharatiya Janata Party

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.